The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Valens GroWorks is Canadian publicly traded biotechnology company executing on its “plants to premium products” objectives through three wholly-owned subsidiaries, located at the Company’s 25,000 square foot facility and greenhouse development in the heart of British Columbia’s Okanagan Valley.
Valeo Pharma is a specialty pharmaceutical company dedicated to the approval and launch of innovative prescription products in Canada. With a focus on neurodegenerative diseases, woman’s health and rare diseases, Valeo Pharma has a growing portfolio of innovative products and a platform to properly manage these products through all stages of commercialization. Headquartered in Kirkland, Quebec, Valeo Pharma has all capabilities internally to register and market health care solutions for Canadian patients. For more information, please visit www.valeopharma.com.
Ventura Cannabis and Wellness Corp. has operations in the US inpatient (detox and residential) and outpatient rehabilitation market and serves clients with addictive and co-occurring disorders, and offers a line of marijuana lifestyle management supplements. While Ventura Cannabis and Wellness Corp. continues to focus on its traditional services it is exploring the possibility of expanding its addiction treatment services and product offering in the marijuana space in some capacity to be determined.
Veritas Pharma Inc. (trading symbol CSE:VRT) is an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions such as chronic pain, emesis (nausea/vomiting), and epilepsy. Using a ‘lean and mean’ approach to product development, the company aims to select candidate cultivars using classical pharmacology techniques and then immediately evaluate them in the clinic to maximize both the Company has applied to Health Canada for a medical marijuana production and distribution license under the Marihuana for Medical Purposes Regulations (the “MMPR“).
Vodis Pharmaceuticals Inc. is positioned to be among the first pharmaceutical corporations in Canada to produce and market medical marijuana under license from Health Canada in accordance with the existing Narcotic Control Regulations (“NCR”) and the new Marihuana for Medical Purposes Regulations (“MMPR”) that came into effect on April 1, 2014. Vodis filed its MMPR in August 2013 and in January 2014 received a ‘ready to build’ letter from Health Canada. IT IS CURRENTLY AWAITING FINAL INSPECTION FROM HEALTH CANADA. The company has been operating under the MMAR regulations at its 12,000 square foot production facility consisting of six rooms. This was recently upgraded to eight rooms consisting of between 40 and 50 lights per room. The estimated production when fully operational under the MMPR license is between 150-200 pounds per month of award-winning cannabis.
Each Cannabis Growth Opportunity Corp share purchase warrant entitles the holder to acquire one common share at a price of $2.50, subject to adjustment, on or prior to 5:00 p.m. (Toronto time) on the expiry date, January 26, 2020. The warrants are subject to an accelerated expiry should certain conditions be met. See the Warrant Indenture for a full description and terms of the warrants.
Wayland is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Langton, Ontario, where it operates a medicinal cannabis cultivation, extraction and distribution business under federal license from the Government of Canada. Wayland, who has federal licenses to cultivate, process and distribute cannabis, services to patients with more than 11,000 total registered patients since inception. Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada in a fully funded 217,000 sq. ft. (20,159 sq. M) build out, to support existing and future patient growth.
Weekend Unlimited Inc. is capitalizing on vast industry relationships to establish a portfolio of cannabis brands throughout North America and internationally. Weekend Unlimited’s brand portfolio includes geographic footholds in California, Washington State, British Columbia and Las Vegas, establishing a strong, versatile foundation for substantial growth. The product portfolio will be focused under the headings of flower, edibles and extracts.
Wildflower is a holistic wellness company headquartered in Vancouver building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts.
Advertisement
Publicité
Advertisement
Publicité
